{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:58:31Z","timestamp":1790812711697,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,7]],"date-time":"2020-11-07T00:00:00Z","timestamp":1604707200000},"content-version":"vor","delay-in-days":129,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004431","name":"Fondation de France","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004431","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-16-RHUS-0007"],"award-info":[{"award-number":["ANR-16-RHUS-0007"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jlr.org"],"crossmark-restriction":true},"short-container-title":["Journal of Lipid Research"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1194\/jlr.d120000835","type":"journal-article","created":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T22:45:35Z","timestamp":1589409935000},"page":"1128-1139","update-policy":"https:\/\/doi.org\/10.1194\/jlr.f110.005975","source":"Crossref","is-referenced-by-count":51,"title":["A high-throughput mass spectrometry-based assay for large-scale profiling of circulating human apolipoproteins"],"prefix":"10.1016","volume":"61","author":[{"given":"Valentin","family":"Blanchard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Gar\u00e7on","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Jaunet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Chemello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Billon-Crossouard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Aguesse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya","family":"Garfa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Famchon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amada","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9dric","family":"Le May","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Pichelin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edith","family":"Bigot-Corbel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Cariou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samy","family":"Hadjadj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Krempf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalyane","family":"Bach-Ngohou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5449-5817","authenticated-orcid":false,"given":"Mika\u00ebl","family":"Croyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1194\/jlr.D120000835_bib1","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1258\/acb.2011.011111","article-title":"Apolipoproteins: metabolic role and clinical biochemistry applications","volume":"48","author":"Dominiczak","year":"2011","journal-title":"Ann. Clin. Biochem."},{"key":"10.1194\/jlr.D120000835_bib2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.18632\/aging.100004","article-title":"Apolipoprotein D in lipid metabolism and its functional implication in atherosclerosis and aging","volume":"1","author":"Perdomo","year":"2009","journal-title":"Aging (Albany NY)."},{"key":"10.1194\/jlr.D120000835_bib3","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1080\/14789450.2017.1374859","article-title":"Advances in quantifying apolipoproteins using LC-MS\/MS technology: implications for the clinic","volume":"14","author":"van den Broek","year":"2017","journal-title":"Expert Rev. Proteomics."},{"key":"10.1194\/jlr.D120000835_bib4","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1177\/0004563219827620","article-title":"Apolipoprotein profiling as a personalized approach to the diagnosis and treatment of dyslipidaemia","volume":"56","author":"Renee Ruhaak","year":"2019","journal-title":"Ann. Clin. Biochem."},{"key":"10.1194\/jlr.D120000835_bib5","doi-asserted-by":"crossref","first-page":"346","DOI":"10.2337\/dc16-1295","article-title":"Serum levels of apolipoproteins and incident type 2 diabetes: a prospective cohort study","volume":"40","author":"Brahimaj","year":"2017","journal-title":"Diabetes Care."},{"key":"10.1194\/jlr.D120000835_bib6","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.jacc.2016.11.042","article-title":"A test in context: lipoprotein(a): diagnosis, prognosis, controversies, and emerging therapies","volume":"69","author":"Tsimikas","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1194\/jlr.D120000835_bib7","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/j.1742-1241.2007.01678.x","article-title":"An ABC of apolipoprotein C-III: a clinically useful new cardiovascular risk factor?","volume":"62","author":"Chan","year":"2008","journal-title":"Int. J. Clin. Pract."},{"key":"10.1194\/jlr.D120000835_bib8","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1046\/j.1365-2362.1999.00431.x","article-title":"Post-prandial chylomicron response may be predicted by a single measurement of plasma apolipoprotein B48 in the fasting state","volume":"29","author":"Smith","year":"1999","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1194\/jlr.D120000835_bib9","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1161\/ATVBAHA.117.310208","article-title":"Stable isotope kinetic study of apoM (apolipoprotein M)","volume":"38","author":"Croyal","year":"2018","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1194\/jlr.D120000835_bib10","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/MOL.0b013e32833af368","article-title":"Mechanisms linking apolipoprotein E isoforms with cardiovascular and neurological diseases","volume":"21","author":"Huang","year":"2010","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1194\/jlr.D120000835_bib11","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jacbts.2019.03.002","article-title":"Reduced lipoprotein(a) associated with the apolipoprotein E2 genotype confers cardiovascular protection in familial hypercholesterolemia","volume":"4","author":"Blanchard","year":"2019","journal-title":"JACC Basic Transl. Sci."},{"key":"10.1194\/jlr.D120000835_bib12","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1021\/pr401060x","article-title":"Assessment of peptide chemical modifications on the development of an accurate and precise multiplex selected reaction monitoring assay for apolipoprotein e isoforms","volume":"13","author":"Mart\u00ednez-Morillo","year":"2014","journal-title":"J. Proteome Res."},{"key":"10.1194\/jlr.D120000835_bib13","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/nprot.2016.057","article-title":"Six alternative proteases for mass spectrometry-based proteomics beyond trypsin","volume":"11","author":"Giansanti","year":"2016","journal-title":"Nat. Protoc."},{"key":"10.1194\/jlr.D120000835_bib14","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1002\/prca.201300034","article-title":"Quantification of seven apolipoproteins in human plasma by proteotypic peptides using fast LC-MS\/MS","volume":"7","author":"Ceglarek","year":"2013","journal-title":"Proteomics Clin. Appl."},{"key":"10.1194\/jlr.D120000835_bib15","doi-asserted-by":"crossref","DOI":"10.1002\/pmic.201700279","article-title":"Targeted on-line SPE-LC-MS\/MS assay for the quantitation of 12 apolipoproteins from human blood","volume":"18","author":"Dittrich","year":"2018","journal-title":"Proteomics."},{"key":"10.1194\/jlr.D120000835_bib16","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1373\/clinchem.2015.246702","article-title":"Automated multiplex LC-MS\/MS assay for quantifying serum apolipoproteins A-I, B, C-I, C-II, C-III, and E with qualitative apolipoprotein E phenotyping","volume":"62","author":"van den Broek","year":"2016","journal-title":"Clin. Chem."},{"key":"10.1194\/jlr.D120000835_bib17","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3390\/proteomes5040027","article-title":"Mass spectrometric studies of apolipoprotein proteoforms and their role in lipid metabolism and type 2 diabetes","volume":"5","author":"Nedelkov","year":"2017","journal-title":"Proteomes."},{"key":"10.1194\/jlr.D120000835_bib18","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/bs.acc.2019.01.006","article-title":"A practical guide to validation and verification of analytical methods in the clinical laboratory","volume":"90","author":"Pum","year":"2019","journal-title":"Adv. Clin. Chem."},{"key":"10.1194\/jlr.D120000835_bib19","doi-asserted-by":"crossref","first-page":"957","DOI":"10.4155\/bio-2018-0061","article-title":"Clinical biomarker validation","volume":"10","author":"Allinson","year":"2018","journal-title":"Bioanalysis."},{"key":"10.1194\/jlr.D120000835_bib20","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1074\/mcp.M113.036095","article-title":"Targeted peptide measurements in biology and medicine: best practices for mass spectrometry-based assay development using a fit-for-purpose approach","volume":"13","author":"Carr","year":"2014","journal-title":"Mol. Cell. Proteomics."},{"key":"10.1194\/jlr.D120000835_bib21","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1194\/jlr.D064618","article-title":"Multiplexed peptide analysis for kinetic measurements of major human apolipoproteins by LC\/MS\/MS","volume":"57","author":"Croyal","year":"2016","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.D120000835_bib22","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1002\/rcm.6734","article-title":"Rapid detection and quantification of apolipoprotein L1 genetic variants and total levels in plasma by ultra-performance liquid chromatography\/tandem mass spectrometry","volume":"27","author":"Zhou","year":"2013","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1194\/jlr.D120000835_bib23","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1194\/jlr.D047829","article-title":"Static and turnover kinetic measurement of protein biomarkers involved in triglyceride metabolism including apoB48 and apoA5 by LC\/MS\/MS","volume":"55","author":"Pan","year":"2014","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.D120000835_bib24","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1194\/jlr.P083576","article-title":"Kinetics of plasma apolipoprotein E isoforms by LC-MS\/MS: a pilot study","volume":"59","author":"Blanchard","year":"2018","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.D120000835_bib25","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1161\/ATVBAHA.115.305835","article-title":"Effects of extended-release nicotinic acid on apolipoprotein (a) kinetics in hypertriglyceridemic patients","volume":"35","author":"Croyal","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1194\/jlr.D120000835_bib26","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0140-6736(86)90837-8","article-title":"Statistical methods for assessing agreement between two methods of clinical measurement","volume":"1","author":"Bland","year":"1986","journal-title":"Lancet."},{"key":"10.1194\/jlr.D120000835_bib27","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1365-2796.2006.01648.x","article-title":"Measurement and meaning of apolipoprotein AI and apolipoprotein B plasma levels","volume":"259","author":"Marcovina","year":"2006","journal-title":"J. Intern. Med."},{"key":"10.1194\/jlr.D120000835_bib28","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.jacc.2016.11.065","article-title":"Very-low-density lipoprotein-associated apolipoproteins predict cardiovascular events and are lowered by inhibition of APOC-III","volume":"69","author":"Pechlaner","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1194\/jlr.D120000835_bib29","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/MOL.0000000000000654","article-title":"Apolipoprotein M: new connections with diet, adipose tissue and metabolic syndrome","volume":"31","author":"Tavernier","year":"2020","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1194\/jlr.D120000835_bib30","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1161\/CIRCULATIONAHA.118.036589","article-title":"Association of APOL1 risk alleles with cardiovascular disease in blacks in the million veteran program","volume":"140","author":"Bick","year":"2019","journal-title":"Circulation."},{"key":"10.1194\/jlr.D120000835_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0021-9150(01)00751-1","article-title":"Apoli\u00adpoprotein A-II, HDL metabolism and atherosclerosis","volume":"164","author":"Tailleux","year":"2002","journal-title":"Atherosclerosis."},{"key":"10.1194\/jlr.D120000835_bib32","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1194\/jlr.R052753","article-title":"Apolipoprotein A-IV: a protein intimately involved in metabolism","volume":"56","author":"Wang","year":"2015","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.D120000835_bib33","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1193032","article-title":"Association of trypanolytic ApoL1 variants with kidney disease in African Americans","volume":"329","author":"Genovese","year":"2010","journal-title":"Science."},{"key":"10.1194\/jlr.D120000835_bib34","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1016\/j.jacc.2009.10.080","article-title":"Apolipoprotein(a) isoforms and the risk of vascular disease: systematic review of 40 studies involving 58,000 participants","volume":"55","author":"Erqou","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1194\/jlr.D120000835_bib35","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1373\/clinchem.2010.152264","article-title":"Simultaneous quantification of apolipoprotein A-I and apolipoprotein B by liquid-chromatography-multiple- reaction-monitoring mass spectrometry","volume":"56","author":"Agger","year":"2010","journal-title":"Clin. Chem."},{"key":"10.1194\/jlr.D120000835_bib36","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jprot.2014.04.030","article-title":"Absolute quantification of apolipoproteins and associated proteins on human plasma lipoproteins","volume":"106","author":"von Zychlinski","year":"2014","journal-title":"J. Proteomics."},{"key":"10.1194\/jlr.D120000835_bib37","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/rcm.6883","article-title":"Simultaneous quantitation and size characterization of apolipoprotein(a) by ultra-performance liquid chromatography\/mass spectrometry","volume":"28","author":"Lassman","year":"2014","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1194\/jlr.D120000835_bib38","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1194\/jlr.P064816","article-title":"Disialylated apolipoprotein C-III proteoform is associated with improved lipids in prediabetes and type 2 diabetes","volume":"57","author":"Koska","year":"2016","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.D120000835_bib39","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.jacl.2016.03.001","article-title":"Posttranslational modifications of apolipoprotein A-II proteoforms in type 2 diabetes","volume":"10","author":"Azizkhanian","year":"2016","journal-title":"J. Clin. Lipidol."},{"key":"10.1194\/jlr.D120000835_bib40","first-page":"18","article-title":"The application of multiple reaction monitoring to assess Apo A-I methionine oxidations in diabetes and cardiovascular disease","volume":"4\u20135","author":"Yassine","year":"2014","journal-title":"Transl. Proteom."},{"key":"10.1194\/jlr.D120000835_bib41","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12014-018-9208-y","article-title":"Investigation of post-translational modifications in type 2 diabetes","volume":"15","author":"Chatterjee","year":"2018","journal-title":"Clin. Proteomics."}],"container-title":["Journal of Lipid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227520435898?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227520435898?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1194\/jlr.D120000835","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,20]],"date-time":"2021-11-20T23:58:52Z","timestamp":1637452732000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022227520435898"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":41,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S0022227520435898"],"URL":"https:\/\/doi.org\/10.1194\/jlr.d120000835","relation":{},"ISSN":["0022-2275"],"issn-type":[{"value":"0022-2275","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]}}}